Exactly.
For example, we now have two projects that are working on using genetically modified bacteria to clean up oil spills in the environment. We have projects using bacterial populations and other micro-organisms in the process of being able to release oil supplies that are trapped in inaccessible locations.
So there are projects going from environment to energy, to human and animal health, biofuels, all of these things, that have their basis in genomics and related sciences, and we see that Canada has built up a platform in the last decade or so. What we now need to do is to make sure we keep that strong and develop it further and especially focus on commercialization of the discoveries we make so that the economic benefits to Canada can flow.
We see most of that happening by working more effectively together in order to use our resources better and to remove barriers. The intellectual property regimes in Canada have been made up of reform related to biotechnology for years. There are process barriers. We've had reports on smart regulation and all the rest of it. None of that has yet produced the kind of streamlining that is absolutely essential.
We think we can compete. What we want is the ability to compete, and that doesn't just mean more investment, although that's critically important. It also means using it more effectively.